Is Semaglutide Vegan? What the Ingredients Actually Tell You

Semaglutide is a laboratory-synthesised peptide; no animal tissue is used to produce the active molecule itself.
Formulation excipients (including polysorbate 80 in the Wegovy injection) may have indirect animal-derived links depending on the manufacturing source.
Neither Wegovy nor Wegovy tablets carries an official vegan certification from the manufacturer, Novo Nordisk.
All licensed semaglutide products for weight management in the UK require a prescription following clinical assessment.

Semaglutide itself is a synthetic peptide — not derived from animals — but whether Wegovy or the Wegovy tablet qualifies as vegan depends on the full formulation, not the active ingredient alone. The excipients and manufacturing processes introduce nuance that matters to anyone following a strict vegan lifestyle. As a prescription-only treatment, semaglutide can only be started after a clinician has assessed your suitability, so any concern about ingredients is worth raising at that stage.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture: formulation ingredients, real-world practice and what to discuss with a prescriber

Is the semaglutide molecule itself derived from animals?

No. Semaglutide is a glucagon-like peptide-1 (GLP-1) analogue produced by recombinant DNA technology. In practical terms, that means it is synthesised in a laboratory using genetically modified yeast or bacterial cells, not extracted from animal tissue. The peptide backbone is designed to mimic a human gut hormone, but the manufacturing route is biotechnological rather than animal-derived.

That distinction matters, but it is only part of the answer. A medicine is more than its active ingredient. Formulated products contain excipients (stabilisers, buffers, preservatives and carriers) and some of those carry their own considerations for vegans.

The NHS medicines page for semaglutide gives a clear overview of the drug class and its general profile, and the full ingredient list for each product sits in the Summary of Product Characteristics published on the electronic Medicines Compendium (eMC).

What do the excipients in Wegovy and the Wegovy tablet contain?

The Wegovy injection's formulation includes disodium phosphate dihydrate, propylene glycol, phenol and polysorbate 80, among other components. Polysorbate 80 is the ingredient most commonly queried by vegans: it is a synthetic surfactant derived from sorbitol (a plant-based sugar alcohol) and oleic acid. Oleic acid can come from either plant sources (such as olive oil) or animal sources (tallow), and manufacturers are not always transparent about which supply chain applies to a specific batch.

The Wegovy tablet (approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management) uses a different formulation. It contains semaglutide alongside SNAC (sodium N-(8-[2-hydroxybenzoyl]amino)caprylate), which is a synthetic absorption enhancer, plus standard tablet excipients. The tablet has no refrigeration requirement, which makes it straightforward to keep in a bag or on a shelf; the injection pen, by contrast, lives in the fridge until its first use.

Neither formulation carries any certification of vegan status from Novo Nordisk. For people whose veganism is rooted in firm ethical or religious grounds, that lack of formal certification is significant even where the theoretical risk of animal-derived content is low.

Does being vegan affect how semaglutide works or who can take it?

A vegan diet does not disqualify anyone from semaglutide treatment, and there is no clinical interaction between a plant-based diet and how the medicine works in the body. The licence covers adults with a BMI of 30 or above, or 27 and above where at least one weight-related condition is present, dietary preference does not change those eligibility thresholds.

One practical point worth noting: semaglutide reduces appetite and slows gastric emptying, which makes it easier to under-eat protein. On a vegan diet, protein sources already require more planning, so people on Wegovy sometimes find it helpful to map out high-protein plant foods (lentils, tofu, edamame, seitan) before starting. That conversation sits with a dietitian or prescriber rather than here, but it is a real consideration.

If you are thinking about treatment and cost is a factor, a plain explanation of what private pricing typically includes is available on the Wegovy costs page.

What should a vegan ask before starting semaglutide?

The most useful step is to read the full excipient list in the Patient Information Leaflet for the specific product and formulation your prescriber is considering, and our semaglutide guide is a good starting point for understanding how the medicine is categorised and prescribed. The eMC hosts the SmPCs for both the Wegovy injection and the Wegovy tablet, and both are publicly accessible.

Beyond the formulation itself, there are two further questions worth raising. First, whether the manufacturing process for the batch uses any animal-derived media (a question that can be put directly to Novo Nordisk via their medical information line). Second, whether there are any interactions with supplements you take, some vegan supplements, such as high-dose iron or calcium formulations, can affect the absorption of other oral medicines and are worth mentioning. If your prescriber is titrating your dose upward, the pages covering semaglutide 1, semaglutide 2, and semaglutide 3 set out what each stage of the dose schedule involves.

Our frequently asked questions page covers a range of practical queries about treatment, and our clinical team is reachable through the contact page if a specific question needs a prescriber's eye before you decide anything.

At nume, every consultation is read by a GPhC-registered Independent Prescriber (a real clinician, not software) on the same day it is submitted. Questions about ingredients, diet and how treatment fits your lifestyle are exactly the kind of thing that review is there to address. If you are ready to explore whether semaglutide is right for you, speak to our prescribers through a free consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions